ATC L: Antineoplastic & Immunomodulating Agents

150 multi-target drugs | Page 5 / 5

InChIKey Drug Name DrugBank ID Groups Targets Clinical
BALLNEJQLSTPIO... Fruquintinib DB11679 approved investigational 3 No
FBKMWOJEPMPVTQ... Incb24360 DB11717 investigational 3 No
DWYRIWUZIJHQKQ... Avapritinib DB15233 approved investigational 3 No
GBLBJPZSROAGMF... Pralsetinib DB15822 approved investigational 3 No
CUABMPOJOBCXJI... Remibrutinib DB16852 approved investigational 3 No
OTBXOEAOVRKTNQ... Anagrelide DB00261 approved investigational 2 No
WYWHKKSPHMUBEB... Tioguanine DB00352 approved investigational 2 No
MKXKFYHWDHIYRV... Flutamide DB00499 approved investigational 2 No
GHASVSINZRGABV... 5-Fluorouracil DB00544 approved investigational 2 No
FPVKHBSQESCIEP... Pentostatin DB00552 approved investigational 2 No
VJJPUSNTGOMMGY... Etoposide DB00773 approved investigational 2 No
RJURFGZVJUQBHK... Dactinomycin DB00970 approved investigational 2 No
UEJJHQNACJXSKW... Thalidomide DB01041 approved investigational withdrawn 2 No
VHOGYURTWQBHIL... Leflunomide DB01097 approved investigational 2 No
SIFNOOUKXBRGGB... Elacestrant DB06374 approved investigational 2 No
BPQMGSKTAYIVFO... Vismodegib DB08828 approved investigational 2 No
UTNUDOFZCWSZMS... Teriflunomide DB08880 approved investigational 2 No
WXCXUHSOUPDCQV... Enzalutamide DB08899 approved investigational 2 No
LIRYPHYGHXZJBZ... Trametinib DB08911 approved investigational 2 No
AOCCBINRVIKJHY... Carmofur DB09010 approved withdrawn 2 No
ACWZRVQXLIRSDF... Binimetinib DB11967 approved investigational 2 No
VOVZXURTCKPRDQ... Asciminib DB12597 approved investigational 2 No
DYLUUSLLRIQKOE... Enasidenib DB13874 approved investigational 2 No
AHYMHWXQRWRBKT... Tepotinib DB15133 approved investigational 2 No
NXQKSXLFSAEQCZ... Sotorasib DB15569 approved investigational 2 No
XIIOFHFUYBLOLW... Selpercatinib DB15685 approved investigational 2 No
RENRQMCACQEWFC... Iptacopan DB16200 approved investigational 2 No
RRMJMHOQSALEJJ... Lazertinib DB16216 approved investigational 2 No
MZPVEMOYADUARK... Orelabrutinib DB16272 investigational 2 No
QCZAWDGAVJMPTA... Vorasidenib DB17097 approved investigational 2 No